Nov 9 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
* On or about Sept 16, co received an investigative subpoena from the california department of insurance
* Materials requested include documents concerning Co's former relationship with Philidor and certain california-based pharmacies and other matters Source text :